Leflunomide can potentiate the anticoagulant effect of warfarin
- PMID: 12468482
- PMCID: PMC137810
- DOI: 10.1136/bmj.325.7376.1333
Leflunomide can potentiate the anticoagulant effect of warfarin
Erratum in
- BMJ. 2003 Feb 22;326(7386):432
Figures
References
-
- Mladenovic V, Domljian Z, Rozman B, Jajic I, Mihajlovic D, Dordevis J, et al. Safety and effectiveness of leflunomide in the treatment of patients with active rheumatoid arthritis: results of a randomised, placebo-controlled, phase II study. Arthritis Rheum. 1995;38:1595–1603. - PubMed
-
- Blaz Rozman for the Leflunomide Investigators' Group. Clinical experience with leflunomide in rheumatoid arthritis. J Rheumatol. 1998;25 suppl 53:27–32S. - PubMed
-
- British Medical Association; Royal Pharmaceutical Society of Great Britain. British national formulary. London: BMA, RPS, March; 2001. (No 41).
-
- Leflunomide information booklet for healthcare professionals—questions and answers. Uxbridge: Hoechst Marion Roussel; 1999.
-
- Summary of product characteristics for Arava. Uxbridge: Hoechst Marion Roussel; 1999.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical